These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 18359230

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Adenosine kinase inhibitors. 6. Synthesis, water solubility, and antinociceptive activity of 5-phenyl-7-(5-deoxy-beta-D-ribofuranosyl)pyrrolo[2,3-d]pyrimidines substituted at C4 with glycinamides and related compounds.
    Bookser BC, Ugarkar BG, Matelich MC, Lemus RH, Allan M, Tsuchiya M, Nakane M, Nagahisa A, Wiesner JB, Erion MD.
    J Med Chem; 2005 Dec 01; 48(24):7808-20. PubMed ID: 16302820
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. QSAR study on adenosine kinase inhibition of pyrrolo[2,3-d]pyrimidine nucleoside analogues using the hansch approach.
    Srikanth K, Debnath B, Jha T.
    Bioorg Med Chem Lett; 2002 Mar 25; 12(6):899-902. PubMed ID: 11958989
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Optimization of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine IGF-1R tyrosine kinase inhibitors towards JNK selectivity.
    Chamberlain SD, Redman AM, Wilson JW, Deanda F, Shotwell JB, Gerding R, Lei H, Yang B, Stevens KL, Hassell AM, Shewchuk LM, Leesnitzer MA, Smith JL, Sabbatini P, Atkins C, Groy A, Rowand JL, Kumar R, Mook RA, Moorthy G, Patnaik S.
    Bioorg Med Chem Lett; 2009 Jan 15; 19(2):360-4. PubMed ID: 19071018
    [Abstract] [Full Text] [Related]

  • 11. 2D Autocorrelation, CoMFA, and CoMSIA modeling of protein tyrosine kinases' inhibition by substituted pyrido[2,3-d]pyrimidine derivatives.
    Caballero J, Fernández M, Saavedra M, González-Nilo FD.
    Bioorg Med Chem; 2008 Jan 15; 16(2):810-21. PubMed ID: 17964795
    [Abstract] [Full Text] [Related]

  • 12. Structural requirements of pyrido[2,3-d]pyrimidin-7-one as CDK4/D inhibitors: 2D autocorrelation, CoMFA and CoMSIA analyses.
    Caballero J, Fernández M, González-Nilo FD.
    Bioorg Med Chem; 2008 Jun 01; 16(11):6103-15. PubMed ID: 18468903
    [Abstract] [Full Text] [Related]

  • 13. Modeling of cyclin-dependent kinase inhibition by 1H-pyrazolo[3,4-d]pyrimidine derivatives using artificial neural network ensembles.
    Fernández M, Tundidor-Camba A, Caballero J.
    J Chem Inf Model; 2005 Jun 01; 45(6):1884-95. PubMed ID: 16309296
    [Abstract] [Full Text] [Related]

  • 14. 3D QSAR models built on structure-based alignments of Abl tyrosine kinase inhibitors.
    Falchi F, Manetti F, Carraro F, Naldini A, Maga G, Crespan E, Schenone S, Bruno O, Brullo C, Botta M.
    ChemMedChem; 2009 Jun 01; 4(6):976-87. PubMed ID: 19326384
    [Abstract] [Full Text] [Related]

  • 15. 5,6,7-trisubstituted 4-aminopyrido[2,3-d]pyrimidines as novel inhibitors of adenosine kinase.
    Perner RJ, Gu YG, Lee CH, Bayburt EK, McKie J, Alexander KM, Kohlhaas KL, Wismer CT, Mikusa J, Jarvis MF, Kowaluk EA, Bhagwat SS.
    J Med Chem; 2003 Nov 20; 46(24):5249-57. PubMed ID: 14613327
    [Abstract] [Full Text] [Related]

  • 16. 4-amino-5-aryl-6-arylethynylpyrimidines: structure-activity relationships of non-nucleoside adenosine kinase inhibitors.
    Matulenko MA, Paight ES, Frey RR, Gomtsyan A, DiDomenico S, Jiang M, Lee CH, Stewart AO, Yu H, Kohlhaas KL, Alexander KM, McGaraughty S, Mikusa J, Marsh KC, Muchmore SW, Jakob CL, Kowaluk EA, Jarvis MF, Bhagwat SS.
    Bioorg Med Chem; 2007 Feb 15; 15(4):1586-605. PubMed ID: 17197188
    [Abstract] [Full Text] [Related]

  • 17. An in silico exploration of the interaction mechanism of pyrazolo[1,5-a]pyrimidine type CDK2 inhibitors.
    Li Y, Gao W, Li F, Wang J, Zhang J, Yang Y, Zhang S, Yang L.
    Mol Biosyst; 2013 Sep 15; 9(9):2266-81. PubMed ID: 23864105
    [Abstract] [Full Text] [Related]

  • 18. Identification and synthesis of substituted pyrrolo[2,3-d]pyrimidines as novel firefly luciferase inhibitors.
    Liu Y, Fang J, Cai H, Xiao F, Ding K, Hu Y.
    Bioorg Med Chem; 2012 Sep 15; 20(18):5473-82. PubMed ID: 22898255
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and activity of novel 5-substituted pyrrolo[2,3-d]pyrimidine analogues as pp60(c-Src) tyrosine kinase inhibitors.
    Olgen S, Isgör YG, Coban T.
    Arch Pharm (Weinheim); 2008 Feb 15; 341(2):113-20. PubMed ID: 18214841
    [Abstract] [Full Text] [Related]

  • 20. Identification of 4-(4-aminopiperidin-1-yl)-7H-pyrrolo[2,3-d]pyrimidines as selective inhibitors of protein kinase B through fragment elaboration.
    Caldwell JJ, Davies TG, Donald A, McHardy T, Rowlands MG, Aherne GW, Hunter LK, Taylor K, Ruddle R, Raynaud FI, Verdonk M, Workman P, Garrett MD, Collins I.
    J Med Chem; 2008 Apr 10; 51(7):2147-57. PubMed ID: 18345609
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.